Companies Related to "Oxaliplatin Capecitabine Celecoxib Gastric Carcinoma" [Most Relevant Company Matches] RSS

08:15 EDT 22nd October 2014 | BioPortfolio

Here are the most relevant search results for "Oxaliplatin Capecitabine Celecoxib Gastric Carcinoma" found in our extensive corporate database of over 50,000 company records.

Showing "Oxaliplatin Capecitabine Celecoxib Gastric Carcinoma" Companies 1–25 of 35

Relevant

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...

Kite Pharma, Inc.

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of cutting-edge immunotherapeutic products to treat different cancer indications. Kite's lead products include antigens associated with a wide variety of tumor types, and are initially being developed for the treatment of renal cell carcinoma...

ACT Biotech Inc.

ACT Biotech (www.actbiotech.com) is a San Francisco-based, privately-held biopharmaceutical company focused on the development and commercialization of targeted cancer drugs. The Company's clinical stage pipeline also includes Telatinib, the most selective oral VEGF/PDGFR/KIT inhibitor ever developed. Telatinib is currently being studied in a Phase 2 trial...

Obalon Therapeutics, Inc.

Obalon is a private medical technology company based in San Diego, California focused on developing innovative, high-quality gastric balloon technology for weight loss therapy. www.obalon.com.

Pharmacia Biotech Incorporated

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injecti...

Hoefer Pharmacia Biotech Incorporated

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injecti...

Probably Relevant

WheyUP

WheyUP provides a healthy and delicious (nonshake) whey protein beverage product with a caffeine energy boost that aids in supporting a healthy lifestyle. The protein drink features 20 g of protein, only has a minuscule 1 g of carbs, is fat and sugar free, and there is only 90 calories in the entire bottle. It’s ideal for those who are seeking to lose...

pharmacia Corporation

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. We have built a portfolio of outstanding products, led by our key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injection,...

Access Pharmaceuticals

Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for patients. Together with our subsidiaries we have proprietary patents or rights to a number of drug delivery platforms,Synthetic polymer targeted delivery,Vitamin mediated targeted delivery, Vitamin me...

ANDERSEN PRODUCTS, INC .

H. W. Andersen Products of California, Inc. has distributed surgical tubes, drains and pumps manufactured by Andersen Products, Inc., gas sterilization products manufactured by Andersen Sterilizers, Inc. and sterilization validation services provided by Andersen Scientific, Inc. for more than 25 years. Andersen was the first on the market to offer a double lumen naso-gastric tube and has continue...

OncoEthix

OncoEthix is a privately held biotechnology company that plans to develop a small portfolio of oncology drug candidates, ensuring a proper foundation for commercial success. The company’s lead product, OTX008, a synthetic small molecule targeted to galectin-1, entered Phase 1 clinical trial in the first quarter of 2012. OncoEthix was incorporated in 2007 and completed a Series A financing ...

ValenTx, Inc.

ValenTx, Inc. is developing a less-invasive, implantable medical device to address morbid obesity. The Company's founding principle was to emulate the proven mechanisms of gastric bypass surgery, but with a less invasive, implantable, and removable device. ValenTx was initially funded by leading medical technology venture capital investors, Sapient Capital, EDF Ventures, Kaiser Permanente, Affinit...

Bariatric Partners, Inc.

Headquartered in Charlotte, North Carolina, Bariatric Partners, Inc. is a national for-profit healthcare company that specializes in partnering with leading bariatric surgeons across the country to provide minimally invasive surgical treatment for the disease of obesity. Bariatric Partners, Inc., along with its physician partners, owns and operates specialty ambulatory surgical centers - branded u...

Tensha Therapeutics

Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. The company’s programs are based on the discovery from the laboratory of Dr. James Bradner at Dana-Farber Cancer Institute of first-in-class, potent small molecule BET bromodomain ...

immatics biotechnologies GmbH

"immatics is a biopharmaceutical company from Tuebingen/Germany. With presently 40 employees immatics develops peptide-based therapeutic vaccines for oncology. The most advanced product candidate, IMA901, addresses the unmet medical need in renal cell carcinoma. Based on very encouraging results from a recently completed phase 1 trial, IMA901 will soon be transferred to phase 2 clinical testing. A...

Copeland's Restaurants

The Al Copeland Foundation has been established in memory of a true New Orleans legend, founder of Popeye's Fried Chicken and Biscuits, humanitarian, and world renowned entrepreneur, whose life was cut short by a rare and aggressive form of cancer, Merkel Cell Carcinoma. The purpose of this organization is to carry on Al Copeland Sr.'s wishes to help others with this type of cancer, aid in researc...

Phoenix Pharmacologics Inc.,

Phoenix Pharmacologics Inc., with its principal headquarterslocated in, San Diego, California, is a privately-held emerging biopharmaceutical company that specializes in developing drugs to treat cancer and related disorders. Two of its protein drugs are in late stage clinical trials: ADI-PEG 20 for the treatment of hepatocellular carcinoma and metastatic melanoma,and Uricase-PEG 20 for the treatm...

AMDL Incorporated

AMDL develops, manufactures, markets and sells various immunodiagnostic kits, used by laboratories in hospital, clinical, and research settings to obtain precise and rapid identification of certain types of cancer and other diseases. We have two proprietary kits: DR-70® for detection of at least 13 different types of cancer (lung, breast, stomach, liver, colo-rectal, ovarian, esophageal, uterine,...

Al Copeland Investments

Founded by legendary restaurateur Al Copeland, Al Copeland Investments (ACI) is one of the premium names in the hospitality industry owning a number of leading food, restaurant and entertainment enterprises. The ACI family of companies includes 50 restaurants, hotels and comedy clubs throughout the United States, including Diversified Food and Seasonings, Copeland's of New Orleans, Copeland's Chee...

Cell Works Incorporated

Cell Works Inc. is an early-stage biomedical company located in Baltimore, Maryland, basing their initial products on research conducted at The Johns Hopkins University (JHU). Cell Works has exclusively licensed certain cell isolation technology from JHU on a worldwide basis. This technology license currently incorporates one patent, one patent application, and related international patent applica...

True Results

True Results, is America’s number one Lap Band provider, having completed more than 16,000 procedures. With an industry-leading network of physicians, healthcare professionals, surgical centers and aftercare specialists, True Results is dedicated to the comprehensive treatment and care of gastric banding patients. True Results’ aftercare program, ...

Cytopia Limited

Cytopia aims to identify new candidate therapeutics (drug leads) for asthma and a range of inflammatory diseases. Many current drugs have significant side effects such as gastric upsets and ulcers and Cytopia's technology has the potential to discover more specific drugs without these side effects.Cytopia has an exclusive, worldwide royalty-free license to commercially exploit technology developed...

LICA Pharmaceuticals A/S

LICA Pharmaceuticals A/S is a new Danish Biopharmaceutical Research and Development company. It was founded in April 2000. The company’s mission is to develop and commercialize novel and unique compounds for the treatment of bacterial and parasitic diseases. The company owns promising internationally acknowledged intellectual proprietary rights on novel chalcone-based compounds and their use as ...

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

Digestive Care, Inc.

DCI is a privately held fully integrated pharmaceutical company dedicated to developing unique pharmaceutical products to alleviate complications and symptoms of gastrointestinal disorders. DCI was founded in 1990. The company holds 15 U.S. and foreign patents and has a national distribution network. The technology of DCI is based on the ability to commercially develop unique drug delivery syst...


More From BioPortfolio on "Oxaliplatin Capecitabine Celecoxib Gastric Carcinoma"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks